Elucidation of accelerated blood clearance phenomenon caused by repeat injection of PEGylated nanocarriers

Yakugaku Zasshi

Volumn 129, Issue 12, 2009, Pages 1445-1451

  Koide, Hiroyuki ^a   Asai, Tomohiro ^a   Hatanaka, Kentaro ^a   Shimizu, Kosuke ^a   Yokoyama, Masayuki ^b   Ishida, Tatsuhiro ^c   Kiwada, Hiroshi ^c   Oku, Naoto ^a  

^a UNIVERSITY OF SHIZUOKA   (Japan)

^b JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Accelerated blood clearance; Liposome; Nanocarrier; Polyethylene glycol; Polymeric micelle

Indexed keywords

NANOCARRIER; PEGYLATED LIPOSOME; UNCLASSIFIED DRUG;

ACCELERATED BLOOD CLEARANCE; B LYMPHOCYTE; CONFERENCE PAPER; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG FORMULATION; MICELLE; NONHUMAN; PLASMA CLEARANCE; POLYMERIZATION; SPLEEN CELL;

DRUG CARRIERS; DRUG DELIVERY SYSTEMS; DRUG DISCOVERY; GENE TRANSFER TECHNIQUES; LIPOSOMES; METABOLIC CLEARANCE RATE; MICELLES; NANOPARTICLES; NANOTECHNOLOGY; PARTICLE SIZE; POLYETHYLENE GLYCOLS;

EID: 73449135495     PISSN: 00316903     EISSN: 13475231     Source Type: Journal    
DOI: 10.1248/yakushi.129.1445     Document Type: Conference Paper

References (21)

1. Risau W., Nature, 386, 671-674 (1997).
2. Muggia F. M., Clin. Cancer Res., 5, 7-8 (1999).
3. Allen T. M., Hansen C., Biochim. Biophys. Acta, 1068, 133-141 (1991).
4. Lasic D. D., Nature, 380, 561-562 (1996).
5. Sakakibara T., Chen F. A., Kida H., Kunieda K., Cuenca R. E., Martin F. J., Bankert R. B., Cancer Res., 56, 3743-3746 (1996).
6. Gaucher G., Dufresne M. H., Sant V. P., Kang N., Maysinger D., Leroux J.C., J. Control. Release, 109, 169-188 (2005).
7. Yokoyama M., Okano T., Sakurai Y., Ekimoto H., Shibazaki C., Kataoka K., Cancer Res., 51, 3229-3236 (1991).
8. Kataoka K., Itaka K., Nishiyama N., Yamasaki Y., Oishi M., Nagasaki Y., Nucleic. Acids Symp. Ser. (Oxf), 49, 17-18 (2005).
9. Laverman P., Brouwers A. H., Dams E. T., Oyen W. J., Storm G., Van Rooijen N., Corstens F. H., Boerman O. C., J. Pharmacol. Exp. Ther., 293, 996-1001 (2000).
10. Ishida T., Ichikawa T., Ichihara M., Sadzuka Y., Kiwada H., J. Control. Release, 95, 403-412 (2004).
11. Ishida T., Ichihara M., Wang X., Kiwada H., J. Control. Release, 115, 243-250 (2006).
12. Ishida T., Atobe K., Wang X., Kiwada H., J. Control. Release, 115, 251-258 (2006).
13. Akita H., Harashima H., Contrib. Nephrol., 159, 13-29 (2008).
14. Asai T., Suzuki Y., Matsushita S., Yonezawa S., Yokota J., Katanasaka Y., Ishida T., Dewa T., Kiwada H., Nango M., Oku N., Biochem. Biophys. Res. Commun., 368, 243-248 (2008).
15. Ishida T., Wang X., Shimizu T., Nawata K., Kiwada H., J. Control. Release, 122, 349-355 (2007).
16. Liu Y. J., Oldfield S., Maclennan I. C., Eur. J. Immunol., 18, 355-362 (1988).
17. Liu Y. J., Zhang J., Lane P. J., Chan E. Y., Maclennan I. C., Eur. J. Immunol., 21, 2951-2962 (1991).
18. Beringue V., Demoy M., Lasmezas C. I., Gouritin B., Weingarten C., Deslys J. P., Andreux J. P., Couvreur P., Dormont D., J. Pathol., 190, 495-502 (2000).
19. Senior J. H., Crit. Rev. Ther. Drug Carrier Syst., 3, 123-193 (1987).
20. Patel H. M., Moghimi S. M., Adv. Drug Deliv. Rev., 32, 45-60 (1998).
21. Ishida T., Harashima H., Kiwada H., Biosci. Rep., 22, 197-224 (2002).